{
    "2015-02-06": [
        "PFE exec says HSP device biz \"differentiates them from the competition,\" giving PFE \"new capabilities\" & a \"new source of revenue growth.\"",
        "PFE Pfizer Not Done With Deals Even After Hospira Purchase - Bloomberg",
        "GSK is planning to partially spin off its HIV drug business, ViiV",
        "PFE's still a likely buyer after its $17B 'hors d'oeuvre'",
        "ACT jump on PFE rumor ?",
        "iCYMI: Why buying Hospira increases the likelihood of a Pfizer split.. #pharma #biosimilars"
    ]
}